Per Artikel

Riset dan Pengabdian Masyarakat Do Research Sosial Service and Innovation

Id	Authors	Author S Id	Title	Year	Source Title	Volume	Issue	Art No	Page Start	Page End	Cited By	Link	Affiliations	Authors With Affiliations	Abstract	Author Keywords	Index Keywords	Publisher	Issn	Pubmed Id	Document Type	Sjr Best Quartile	Sjr	Sjr Rank
Display # Page 88 of 93 Start Prev 83 84 85 86 87 88 89 90 91 92 Next End
3(10)
No records
515	Scheibein F., Stowe M.J., Arya S., Morgan N., Shirasaka T., Grandinetti P., Saad N.A., Ghosh A., Vadivel R., Ratta-apha W., Pant S.B., Ransing R., Ramalho R., Bruschi A., Maiti T., HA A.Y., Delic M., Jain S., Peyron E., Siste K., Onoria J., Boujraf S., Dannatt L., Schellekens A., Calvey T.	57212313904;57217388837;35463222300;57201914207;7005625709;55487378900;57219875515;36833820900;57219874702;35604346900;36114863900;57190296865;56789745200;35298539700;57193679395;57222620752;24476120800;57207211289;57205355338;55644113100;57219876130;57220277366;57200537348;14323807600;55634512900;	Responding to COVID-19: Emerging Practices in Addiction Medicine in 17 Countries	2021	Frontiers in Psychiatry	12		634309			3	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103517973&doi=10.3389%2ffpsyt.2021.634309&partnerID=40&md5=5075a0b04e57dd3c3530b131f94ef9a7	School of Health Sciences, Waterford Institute of Technology, Waterford, Ireland; Department of Family Medicine, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; State Drug Dependence Treatment Centre, Institute of Mental Health, Pt Bhagwat Dayal Sharma, University of Health Sciences, Rohtak, India; University of the Witwatersrand, Johannesburg, South Africa; Department of Psychiatry, Teine Keijinkai Medical Center, Sapporo, Japan; Addiction Services (SerD), Department of Territorial Services, ASL Teramo, Teramo, Italy; Department of Psychiatry, Ain Shams University, Cairo, Egypt; Drug Deaddiction and Treatment Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India; Waikato District Health Board, Waikato, New Zealand; Faculty of Medicine Siriraj Hospital, Mahidol University, Salaya, Thailand; Department of Psychiatry and Mental Health, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal; Department of Psychiatry, BKL Walawalkar Rural Medical College, Ratnagiri, India; Department of Social and Community Health, School of Population Health, The University of Auckland, Auckland, New Zealand; Department of Mental Health, ASL Viterbo, Viterbo, Italy; Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India; Department of Psychological Medicine, University Malaya Centre of Addiction Sciences (UMCAS), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Center for Treatment of Drug Addiction, University Psychiatric Clinic Ljubljana, Ljubljana, Slovenia; Department of Psychiatry, Heritage Institute of Medical Sciences (HIMS), Varanasi, India; AddiPsy, Lyon, France; Department of Psychiatry, Faculty of Medicine, Universitas Indonesia-Ciptomangunkusumo Hospital, Jakarta, Indonesia; Department of Psychiatry, College of Health Sciences, Makerere University, Kampala, Uganda; Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University of Fez, Fes, Morocco; Department of Psychiatry and Mental Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; Radboud University Medical Centre, Nijmegen, Netherlands; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa	Scheibein, F., School of Health Sciences, Waterford Institute of Technology, Waterford, Ireland; Stowe, M.J., Department of Family Medicine, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; Arya, S., State Drug Dependence Treatment Centre, Institute of Mental Health, Pt Bhagwat Dayal Sharma, University of Health Sciences, Rohtak, India; Morgan, N., University of the Witwatersrand, Johannesburg, South Africa; Shirasaka, T., Department of Psychiatry, Teine Keijinkai Medical Center, Sapporo, Japan; Grandinetti, P., Addiction Services (SerD), Department of Territorial Services, ASL Teramo, Teramo, Italy; Saad, N.A., Department of Psychiatry, Ain Shams University, Cairo, Egypt; Ghosh, A., Drug Deaddiction and Treatment Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India; Vadivel, R., Waikato District Health Board, Waikato, New Zealand; Ratta-apha, W., Faculty of Medicine Siriraj Hospital, Mahidol University, Salaya, Thailand; Pant, S.B., Department of Psychiatry and Mental Health, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal; Ransing, R., Department of Psychiatry, BKL Walawalkar Rural Medical College, Ratnagiri, India; Ramalho, R., Department of Social and Community Health, School of Population Health, The University of Auckland, Auckland, New Zealand; Bruschi, A., Department of Mental Health, ASL Viterbo, Viterbo, Italy; Maiti, T., Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India; HA, A.Y., Department of Psychological Medicine, University Malaya Centre of Addiction Sciences (UMCAS), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Delic, M., Center for Treatment of Drug Addiction, University Psychiatric Clinic Ljubljana, Ljubljana, Slovenia; Jain, S., Department of Psychiatry, Heritage Institute of Medical Sciences (HIMS), Varanasi, India; Peyron, E., AddiPsy, Lyon, France; Siste, K., Department of Psychiatry, Faculty of Medicine, Universitas Indonesia-Ciptomangunkusumo Hospital, Jakarta, Indonesia; Onoria, J., Department of Psychiatry, College of Health Sciences, Makerere University, Kampala, Uganda; Boujraf, S., Faculty of Medicine and Pharmacy, Sidi Mohamed Ben Abdellah University of Fez, Fes, Morocco; Dannatt, L., Department of Psychiatry and Mental Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; Schellekens, A., Radboud University Medical Centre, Nijmegen, Netherlands; Calvey, T., Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa	[No abstract available]	addiction medicine; behaviourial addictions; best practice; COVID-19; drug policy; guidelines; substance use	addiction; addiction medicine; Article; coronavirus disease 2019; health care policy; human; international cooperation; practice guideline; substance use	Frontiers Media S.A.	16640640		Article	Q1	1363	2668	View
516	Rosa B.A., Snowden C., Martin J., Fischer K., Kupritz J., Beshah E., Supali T., Gankpala L., Fischer P.U., Urban J.F., Jr., Mitreva M.	15519661800;57215576664;56537265100;55807725800;57211116674;6506448106;6602742029;55801653400;23567680200;7202366458;6507392205;	Whipworm-Associated Intestinal Microbiome Members Consistent Across Both Human and Mouse Hosts	2021	Frontiers in Cellular and Infection Microbiology	11		637570			3	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85103118895&doi=10.3389%2ffcimb.2021.637570&partnerID=40&md5=27cf0d3a842448c6a8e6d26ccd8dd43e	Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States; U.S. Department of Agriculture, Agricultural Research Service, Beltsville Agricultural Research Center, Animal Parasitic Diseases Laboratory, Beltsville, MD, United States; Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Public Health and Medical Research, National Public Health Institute of Liberia, Charlesville, Liberia; Department of Genetics, Washington University School of Medicine, St. Louis, MO, United States; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, United States	Rosa, B.A., Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States; Snowden, C., Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States; Martin, J., Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States; Fischer, K., Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States; Kupritz, J., Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States; Beshah, E., U.S. Department of Agriculture, Agricultural Research Service, Beltsville Agricultural Research Center, Animal Parasitic Diseases Laboratory, Beltsville, MD, United States; Supali, T., Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Gankpala, L., Public Health and Medical Research, National Public Health Institute of Liberia, Charlesville, Liberia; Fischer, P.U., Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States; Urban, J.F., Jr., U.S. Department of Agriculture, Agricultural Research Service, Beltsville Agricultural Research Center, Animal Parasitic Diseases Laboratory, Beltsville, MD, United States; Mitreva, M., Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, United States, Department of Genetics, Washington University School of Medicine, St. Louis, MO, United States, McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, United States	The human whipworm Trichuris trichiura infects 289 million people worldwide, resulting in substantial morbidity. Whipworm infections are difficult to treat due to low cure rates and high reinfection rates. Interactions between whipworm and its host’s intestinal microbiome present a potential novel target for infection control or prevention but are very complicated and are identified using inconsistent methodology and sample types across the literature, limiting their potential usefulness. Here, we used a combined 16S rRNA gene OTU analysis approach (QIIME2) for samples from humans and mice infected with whipworm (T. trichiura and T. muris, respectively) to identify for the first time, bacterial taxa that were consistently associated with whipworm infection spanning host species and infection status using four independent comparisons (baseline infected vs uninfected and before vs after deworming for both humans and mice). Using these four comparisons, we identified significant positive associations for seven taxa including Escherichia, which has been identified to induce whipworm egg hatching, and Bacteroides, which has previously been identified as a major component of the whipworm internal microbiome. We additionally identified significant negative associations for five taxa including four members of the order Clostridiales, two from the family Lachnospiraceae, including Blautia which was previously identified as positively associated with whipworm in independent human and mouse studies. Using this approach, bacterial taxa of interest for future association and mechanistic studies were identified, and several were validated by RT-qPCR. We demonstrate the applicability of a mouse animal model for comparison to human whipworm infections with respect to whipworm-induced intestinal microbiome disruption and subsequent restoration following deworming. Overall, the novel cross-species analysis approach utilized here provides a valuable research tool for studies of the interaction between whipworm infection and the host intestinal microbiome. © Copyright © 2021 Rosa, Snowden, Martin, Fischer, Kupritz, Beshah, Supali, Gankpala, Fischer, Urban and Mitreva.	animal model; helminth; intestinal microbiota; microbiome; whipworm	albendazole; ivermectin; mebendazole; RNA 16S; RNA 16S; adult; ancylostomiasis; Article; Bacteroides; Blautia; child; Clostridiales; DNA extraction; Escherichia; feces analysis; female; gene sequence; human; infection control; intestine flora; Lachnospiraceae; male; molecular genetics; morbidity; nonhuman; polymerase chain reaction; real time polymerase chain reaction; reverse transcription polymerase chain reaction; taxonomy; trichuriasis; Trichuris muris; Trichuris trichiura; animal; genetics; microflora; mouse; trichuriasis; Trichuris; Animals; Gastrointestinal Microbiome; Humans; Mice; Microbiota; RNA, Ribosomal, 16S; Trichuriasis; Trichuris	Frontiers Media S.A.	22352988	33777847	Article	Q1	1812	1607	View
555	Susanto A.D., Winardi W., Hidayat M., Wirawan A.	57190425587;57211654146;56435992700;57221412258;	The use of indoor plant as an alternative strategy to improve indoor air quality in Indonesia	2021	Reviews on Environmental Health	36	1		95	99	3	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85094149752&doi=10.1515%2freveh-2020-0062&partnerID=40&md5=a7a8a53669f01afb3fc072e87f174a11	Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jl. Persahabatan Raya No.1, Jakarta, 13230, Indonesia; Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Mataram, Mataram, Indonesia; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jakarta, Indonesia	Susanto, A.D., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jl. Persahabatan Raya No.1, Jakarta, 13230, Indonesia; Winardi, W., Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia; Hidayat, M., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Mataram, Mataram, Indonesia; Wirawan, A., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia/Persahabatan Hospital, Jakarta, Indonesia	Indoor air pollution marked with decreased air quality below the set standard. The quality of indoor air is determined by ambient air quality as well as by a harmful substance resulting from the household activity. Indoor air pollution may cause several problems such as sick building syndrome, chronic obstructive pulmonary disease (COPD), asthma, lung cancer, and is responsible for nearly two million death in developing countries. One of the interesting research topics to overcome the indoor air pollution problem is the application of indoor plants. Although there are no established criteria to specify the best indoor plant, several studies have revealed the capability of a particular indoor plant to remove the harmful substances. This paper summarizes important information about indoor air pollution and provides the evidence-based insight of indoor plant usefulness as an alternative way for indoor air remediation. © 2021 De Gruyter. All rights reserved.	Air pollution; Air quality; Indoor air pollution	ecosystem restoration; human; Indonesia; indoor air pollution; plant; prevention and control; procedures; Air Pollution, Indoor; Environmental Restoration and Remediation; Humans; Indonesia; Plants	De Gruyter Open Ltd	00487554	32920542	Review	Q2	644	7826	View
578	Arguni E., Karyanti M.R., Satari H.I., Hadinegoro S.R.	8520598700;56290680800;57226214366;56893685800;	Diphtheria outbreak in Jakarta and Tangerang, Indonesia: Epidemiological and clinical predictor factors for death	2021	PLoS ONE	16	2 February	e0246301			3	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100508974&doi=10.1371%2fjournal.pone.0246301&partnerID=40&md5=d5c31533e8d632bb7459927c7da0cce2	Department of Child Health, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia; Department of Pediatric, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia	Arguni, E., Department of Child Health, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia; Karyanti, M.R., Department of Pediatric, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Satari, H.I., Department of Pediatric, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Hadinegoro, S.R., Department of Pediatric, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia	Background In 2017, a diphtheria outbreak occurred in several provinces in Indonesia. The aim of this study was to identify predictors of mortality outcome of pediatric patients with clinical diphtheria. Methods A retrospective cohort study was conducted using patient medical records at five referral hospitals in the Province of Jakarta and one in Tangerang District, Banten Province during January 2017 to 31 August 2018. All children in the age group of 1-18 years old discharged with diagnosis of clinical diphtheria formed the study group. All anonymized patient data were evaluated for demographic issues, clinical features, immunization status, complication, laboratory profiles and outcome. Results A total of 283 patients with clinical diphtheria were included in the study group with case fatality rate of 3.5%. All mortal patients had the complication of myocarditis. Regression analyses revealed factors for predicting mortality. Incomplete primary diphtheria toxoid immunization, stridor, bull neck, leukocytosis ≥15 ×109 cells/L and thrombocytopenia ≤150 x109 cells/L in each combination for 2 predictors modeling were correlated with death. Conclusions We report key predictors of mortality in pediatric patients with clinical diphtheria. The presence of these features when admitted to the hospital must be taken into account, because they can lead to fatal outcome. © 2021 Arguni et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.		adolescent; child; cohort analysis; complication; diphtheria; epidemic; female; hospitalization; human; immunization; Indonesia; infant; male; medical record; mortality; myocarditis; preschool child; regression analysis; retrospective study; vaccination; Adolescent; Child; Child, Preschool; Cohort Studies; Diphtheria; Disease Outbreaks; Female; Hospitalization; Humans; Immunization; Indonesia; Infant; Male; Medical Records; Myocarditis; Regression Analysis; Retrospective Studies; Vaccination	Public Library of Science	19326203	33539453	Article	Q1	990	4434	View
585	Silitonga P., Bustamam A., Muradi H., Mangunwardoyo W., Dewi B.E.	57219406661;36815737800;57188977950;24544449900;24076058600;	Comparison of dengue predictive models developed using artificial neural network and discriminant analysis with small dataset	2021	Applied Sciences (Switzerland)	11	3	943	1	16	3	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099695109&doi=10.3390%2fapp11030943&partnerID=40&md5=3a9bba4cf9ba9dacfef04d7349c81f4b	Department of Mathematics, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Kampus Baru UI, Depok, 16424, Indonesia; Department of Mathematics, Faculty of Science and Information Technology, Institut Sains dan Teknologi Nasional, Jl.Moh Kahfi II Srengseng Sawah Jagakarsa, Jakarta Selatan, 12640, Indonesia; Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Kampus Baru UI, Depok, 16424, Indonesia; Department of Microbiology, Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya no. 5, Kota Jakarta Pusat, Daerah Khusus Ibu Kota Jakarta, 10430, Indonesia	Silitonga, P., Department of Mathematics, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Kampus Baru UI, Depok, 16424, Indonesia; Bustamam, A., Department of Mathematics, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Kampus Baru UI, Depok, 16424, Indonesia; Muradi, H., Department of Mathematics, Faculty of Science and Information Technology, Institut Sains dan Teknologi Nasional, Jl.Moh Kahfi II Srengseng Sawah Jagakarsa, Jakarta Selatan, 12640, Indonesia; Mangunwardoyo, W., Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Kampus Baru UI, Depok, 16424, Indonesia; Dewi, B.E., Department of Microbiology, Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya no. 5, Kota Jakarta Pusat, Daerah Khusus Ibu Kota Jakarta, 10430, Indonesia	In Indonesia, dengue has become one of the hyperendemic diseases. Dengue consists of three clinical phases—febrile phase, critical phase, and recovery phase. Many patients have died in the critical phase due to the lack of proper and timely treatment. Therefore, we developed models that can predict the severity level of dengue based on the laboratory test results of the corresponding patients using Artificial Neural Network (ANN) and Discriminant Analysis (DA). In developing the models, we used a very small dataset. It is shown that ANN models developed using logistic and hyperbolic tangent activation function with 70% training data yielded the highest accuracy (90.91%), sensitivity (91.11%), and specificity (95.51%). This is the proposed model in this research. The proposed model will be able to help physicians in predicting the severity level of dengue patients before entering the critical phase. Furthermore, it will ease physicians in treating dengue patients early, so fatal cases or deaths can be avoided. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.	Artificial neural network; Dengue; Discriminant analysis		MDPI AG	20763417		Article	Q2	435	11324	View
735	Librianto D., Suwarto S., Imran D., Pramukti H., Saleh I., Ipang F., Utami W.S., Aprilya D.	57192894799;8443626100;57226756146;57223395589;57191511801;57226749417;57226736196;57193710642;	An extremely rare case of upper thoracic salmonella infection	2021	Orthopedic Research and Reviews	13			107	112	3	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112502092&doi=10.2147%2fORR.S319616&partnerID=40&md5=02436420140f9c1ad84a7f2eb880eee2	Department of Orthopedic and Traumatology, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Jakarta Spine Center, Pondok Indah Hospital, Jakarta, Indonesia; Department of Internal Medicine, Pondok Indah Hospital, Jakarta, Indonesia; Department of Neurology, Pondok Indah Hospital, Jakarta, Indonesia	Librianto, D., Department of Orthopedic and Traumatology, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Jakarta Spine Center, Pondok Indah Hospital, Jakarta, Indonesia; Suwarto, S., Department of Internal Medicine, Pondok Indah Hospital, Jakarta, Indonesia; Imran, D., Department of Neurology, Pondok Indah Hospital, Jakarta, Indonesia; Pramukti, H., Department of Internal Medicine, Pondok Indah Hospital, Jakarta, Indonesia; Saleh, I., Department of Orthopedic and Traumatology, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Ipang, F., Department of Orthopedic and Traumatology, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Jakarta Spine Center, Pondok Indah Hospital, Jakarta, Indonesia; Utami, W.S., Jakarta Spine Center, Pondok Indah Hospital, Jakarta, Indonesia; Aprilya, D., Department of Orthopedic and Traumatology, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia	Background: Vertebral osteomyelitis is rare. Finding the right etiological agent is important to administer antibiotic regimen accordingly. The occurrence of this disease in endemic countries raises the susceptibility of a more common infection such as tuberculosis and pyogenic bacteria. Salmonella spp. infection is also common in endemic countries; however, extra-intestinal manifestation is very rare. Methods: We present an extremely rare case of salmonella vertebral osteomyelitis (SVO) in the upper thoracic vertebrae of a 64-year-old patient with history of cardiac surgery and other pre-existing comorbidities. SVO was treated by antibiotics, surgical debridement and spinal stabilization. Results: Three weeks after surgery and intravenous antibiotics, the patient recovered and was discharged without fever and back pain, with excellent motoric improvement. Conclusion: Salmonella infection must be considered to be one of possible etiological agents in patients with suggestive spondylitis in emerging countries, especially in those with comorbidities. © 2021 Librianto et al.	Osteomyelitis; Salmonella; Spondylitis; Thoracic spine		Dove Medical Press Ltd	11791462		Article	Q2	707	7037	View
765	Tan J.W.C., Chew D.P., Brieger D., Eikelboom J., Montalescot G., Ako J., Kim B.-K., Quek D.K.L., Aitken S.J., Chow C.K., Chour S., Tse H.F., Kaul U., Firdaus I., Kubo T., Liew B.W., Chong T.T., Sin K.Y.K., Yeh H.-I., Buddhari W., Chunhamaneewat N., Hasan F., Fox K.A.A., Nguyen Q.N., Lo S.T.H.	14829599000;7102026332;7004107910;7006303000;7102302494;6701389098;35189204900;57213290935;57225921713;8871779800;57225956090;7006070805;7102340294;55796864700;57226325834;57205155828;36609879000;57223949258;57225966367;57192991797;6505509528;57225971750;57224650893;39962151600;7401542169;	2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome	2021	European Cardiology Review	16		e26			3	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109820982&doi=10.15420%2fECR.2020.45&partnerID=40&md5=349f92694e4c018a59343a627d38ced6	National Heart Centre, Singapore, Singapore; Sengkang General Hospital, Singapore, Singapore; College of Medicine and Public Health, Flinders University, Adelaide, Australia; Concord Repatriation General Hospital, University of Sydney, Sydney, Australia; McMaster UniversityON, Canada; Sorbonne University, Paris, France; ACTION Study Group, France; Pitié-Salpêtrière University Hospital (AP-HP), Paris, France; Kitasato University and Hospital, Kanagawa, Japan; Yonsei University College of Medicine, South Korea; Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia; University of Sydney, Sydney, Australia; Westmead Applied Research Centre, University of Sydney, Sydney, Australia; Westmead Hospital, Sydney, Australia; Calmette Hospital, Phnom Penh, Cambodia; Queen Mary Hospital, University of Hong Kong, Hong Kong; Batra Hospital and Medical Research Center, New Delhi, India; Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Wakayama Medical University, Wakayama, Japan; Changi General Hospital, Singapore, Singapore; Singapore General Hospital, Singapore, Singapore; MacKay Memorial Hospital, MacKay Medical College, Taipei, Taiwan; King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Siriraj Hospital, Mahidol University, Bangkok, Thailand; Heart & Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates; University of Edinburgh, Edinburgh, United Kingdom; Hanoi Medical University, Vietnam National Heart Institute, Hanoi, Viet Nam; Liverpool Hospital, Sydney, Australia	Tan, J.W.C., National Heart Centre, Singapore, Singapore, Sengkang General Hospital, Singapore, Singapore; Chew, D.P., College of Medicine and Public Health, Flinders University, Adelaide, Australia; Brieger, D., Concord Repatriation General Hospital, University of Sydney, Sydney, Australia; Eikelboom, J., McMaster UniversityON, Canada; Montalescot, G., Sorbonne University, Paris, France, ACTION Study Group, France, Pitié-Salpêtrière University Hospital (AP-HP), Paris, France; Ako, J., Kitasato University and Hospital, Kanagawa, Japan; Kim, B.-K., Yonsei University College of Medicine, South Korea; Quek, D.K.L., Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia; Aitken, S.J., University of Sydney, Sydney, Australia; Chow, C.K., Westmead Applied Research Centre, University of Sydney, Sydney, Australia, Westmead Hospital, Sydney, Australia; Chour, S., Calmette Hospital, Phnom Penh, Cambodia; Tse, H.F., Queen Mary Hospital, University of Hong Kong, Hong Kong; Kaul, U., Batra Hospital and Medical Research Center, New Delhi, India; Firdaus, I., Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Kubo, T., Wakayama Medical University, Wakayama, Japan; Liew, B.W., Changi General Hospital, Singapore, Singapore; Chong, T.T., Singapore General Hospital, Singapore, Singapore; Sin, K.Y.K., National Heart Centre, Singapore, Singapore; Yeh, H.-I., MacKay Memorial Hospital, MacKay Medical College, Taipei, Taiwan; Buddhari, W., King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Chunhamaneewat, N., Siriraj Hospital, Mahidol University, Bangkok, Thailand; Hasan, F., Heart & Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates; Fox, K.A.A., University of Edinburgh, Edinburgh, United Kingdom; Nguyen, Q.N., Hanoi Medical University, Vietnam National Heart Institute, Hanoi, Viet Nam; Lo, S.T.H., Liverpool Hospital, Sydney, Australia	The unique characteristics of patients with chronic coronary syndrome (CCS) in the Asia-Pacific region, heterogeneous approaches because of differences in accesses and resources and low number of patients from the Asia-Pacific region in pivotal studies, mean that international guidelines cannot be routinely applied to these populations. The Asian Pacific Society of Cardiology developed these consensus recommendations to summarise current evidence on the management of CCS and provide recommendations to assist clinicians treat patients from the region. The consensus recommendations were developed by an expert consensus panel who reviewed and appraised the available literature, with focus on data from patients in Asia-Pacific. Consensus statements were developed then put to an online vote. The resulting recommendations provide guidance on the assessment and management of bleeding and ischaemic risks in Asian CCS patients. Furthermore, the selection of long-term antithrombotic therapy is discussed, including the role of single antiplatelet therapy, dual antiplatelet therapy and dual pathway inhibition therapy. © 2021 Radcliffe Group Ltd. All rights reserved.	Anticoagulant; Antiplatelet; Asia-Pacific; Bleeding; Chronic coronary syndrome; Consensus; Ischaemia	acetylsalicylic acid; anticoagulant agent; clopidogrel; prasugrel; ticagrelor; age; anticoagulant therapy; Article; Asia; bleeding risk score; brain hemorrhage; cardiac patient; consensus; coronary artery disease; dual antiplatelet therapy; gastrointestinal hemorrhage; heart muscle ischemia; high risk patient; human; percutaneous coronary intervention; thrombosis	Radcliffe Medical Media	17583756		Article	Q2	864	5422	View
790	Wardhani S.O., Fajar J.K., Wulandari L., Soegiarto G., Purnamasari Y., Asmiragani A., Maliga H.A., Ilmawan M., Seran G., Iskandar D.S., Ndapa C.E., Hamat V., Wahyuni R.A., Cyntia L.O.S., Maarang F.M., Beo Y.A., Adar O.A., Rakhmadhan I.M., Shantikaratri E.T., Putri A.S.D., Wahdini R., Broto E.P., Suwanto A.W., Tamara F., Mahendra A.I., Winoto E.S., Krisna P.A., Harapan H.	57193196381;56156139600;52464692000;57193717004;57208736262;57222959533;57222334227;57217182580;57224455829;57224438531;57224439885;57224449332;57224455629;57224455121;57224456392;57224446473;57224439160;57224438662;57224448392;57224441818;57224441565;57224444725;57224449941;57192950403;57202301766;57215222980;57215221274;55844857500;	Association between convalescent plasma and the risk of mortality among patients with COVID-19: A meta-analysis	2021	F1000Research	10		64			3	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107586864&doi=10.12688%2ff1000research.36396.3&partnerID=40&md5=8ed63ca0af3edd475d763e27b3e86db9	Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, 60286, Indonesia; Division of Allergy and Immunology, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, 60286, Indonesia; Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Department of Biomedical Sciences, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Department of Midwifery, Faculty of Medicine, University Brawijaya, Malang, 65145, Indonesia; Department of Nursing, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Department of Neurosurgery, Faculty of Medicine, Universitas Airlangga, Surabaya, 60286, Indonesia; Department of Radiology, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, 23111, Indonesia	Wardhani, S.O., Division of Hematology and Oncology, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Fajar, J.K., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Wulandari, L., Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, 60286, Indonesia; Soegiarto, G., Division of Allergy and Immunology, Department of Internal Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, 60286, Indonesia; Purnamasari, Y., Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Asmiragani, A., Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Maliga, H.A., Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Ilmawan, M., Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Seran, G., Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia; Iskandar, D.S., Department of Biomedical Sciences, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Ndapa, C.E., Department of Midwifery, Faculty of Medicine, University Brawijaya, Malang, 65145, Indonesia; Hamat, V., Department of Midwifery, Faculty of Medicine, University Brawijaya, Malang, 65145, Indonesia; Wahyuni, R.A., Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Cyntia, L.O.S., Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Maarang, F.M., Department of Nursing, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Beo, Y.A., Department of Nursing, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Adar, O.A., Department of Midwifery, Faculty of Medicine, University Brawijaya, Malang, 65145, Indonesia; Rakhmadhan, I.M., Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Shantikaratri, E.T., Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Putri, A.S.D., Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Wahdini, R., Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Broto, E.P., Department of Neurosurgery, Faculty of Medicine, Universitas Airlangga, Surabaya, 60286, Indonesia; Suwanto, A.W., Department of Radiology, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Tamara, F., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Mahendra, A.I., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Winoto, E.S., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Krisna, P.A., Brawijaya Internal Medicine Research Center, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, 65145, Indonesia; Harapan, H., Medical Research Unit, School of Medicine, Universitas Syiah Kuala, Banda Aceh, 23111, Indonesia	Background: Convalescent plasma (CCP) has been used for treating some infectious diseases; however, the efficacy of CCP in coronavirus disease 2019 (COVID-19) remains controversial. The aim of this research was to assess the efficacy of CCP as an adjunctive treatment in COVID-19 patients. Methods: Embase, PubMed, Web of Science, Cochrane and MedRix were searched for potentially relevant articles. All included papers were assessed for the quality using modified Jadad scale and Newcastle-Ottawa scale for randomized controlled trial (RCT) and non - RCT, respectively. We used a Q test and Egger test to assess the heterogeneity and publication bias among studies, respectively. Mortality rates between patients treated with standard treatment and standard treatment with CCP were compared using a Z test. Results: A total of 12 papers consisting of three cross-sectional studies, one prospective study, five retrospective studies, and three RCT studies were included in our analysis. Of them, a total of 1,937 patients treated with CCP and 3,405 patients without CCP were included. The risk of mortality was 1.92-fold higher in patients without CCP compared to patients treated with CCP (OR: 1.92; 95%CI: 1.33, 2.77; p=0.0005). In severe COVID-19 sub-group analysis, we found that patients without CCP had a 1.32 times higher risk of mortality than those treated with CCP (OR: 1.32; 95%CI: 1.09, 1.60; p=0.0040). Conclusions: CCP, as adjunctive therapy, could reduce the mortality rate among COVID-19 patients. © 2021 Wardhani SO et al.	Convalescent plasma; COVID-19; Mortality; Outcomes; Passive immunization	convalescent plasma; Article; clinical effectiveness; clinical observation; consensus; coronavirus disease 2019; correlation analysis; data analysis software; disease association; disease severity; Egger test; fixed effect model; forest plot; high risk patient; human; kappa statistics; meta analysis; mortality risk; Newcastle-Ottawa scale; nonhuman; outcome assessment; passive immunization; publication bias; quality control; random effect model; randomized controlled trial (topic); risk reduction; sample size; statistical analysis; statistical model; study design; subgroup analysis; systematic review; Coronavirus infection; therapy; treatment outcome; Coronavirus Infections; COVID-19; Humans; Immunization, Passive; SARS-CoV-2; Treatment Outcome	F1000 Research Ltd	20461402	34136130	Article	Q1	1099	3793	View
860	Wuyung P.E., Rahadiati F.B., Tjahjadi H., Salinah S., Kusmardi K., Kodariah R., Wiweko B.	57192889605;57222312428;57210953454;57222311659;56966625300;14010667100;43061741400;	Histopathology and Arid1a Expression in Endometriosis-Associated Ovarian Carcinoma (EAOC) Carcinogenesis Model with Endometrial Autoimplantation and DMBA Induction	2021	Asian Pacific Journal of Cancer Prevention	22	2		553	558	3	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102225233&doi=10.31557%2fAPJCP.2021.22.2.553&partnerID=40&md5=0851ed3cc33bf297db42accf77d7988a	Department of Anatomical Pathology, Medicine Universitas Indonesia; Animal Research Facilities, Indonesian Medical Education and Research Institute, Medicine Universitas Indonesia; Specialty Programme in Anatomical Pathology, Department of Anatomical Pathology, Medicine Universitas Indonesia; Department of Obstetrics and Gynecology, Medicine Universitas Indonesia; Indonesian Medical Education and Research Institute, Medicine Universitas Indonesia	Wuyung, P.E., Department of Anatomical Pathology, Medicine Universitas Indonesia, Animal Research Facilities, Indonesian Medical Education and Research Institute, Medicine Universitas Indonesia; Rahadiati, F.B., Specialty Programme in Anatomical Pathology, Department of Anatomical Pathology, Medicine Universitas Indonesia; Tjahjadi, H., Department of Anatomical Pathology, Medicine Universitas Indonesia; Salinah, S., Department of Anatomical Pathology, Medicine Universitas Indonesia; Kusmardi, K., Department of Anatomical Pathology, Medicine Universitas Indonesia; Kodariah, R., Department of Anatomical Pathology, Medicine Universitas Indonesia; Wiweko, B., Department of Obstetrics and Gynecology, Medicine Universitas Indonesia, Indonesian Medical Education and Research Institute, Medicine Universitas Indonesia	Background: Ovarian carcinoma is one of the most deadly malignancies in the gynecologic field. The cause is not yet known, and the clinical symptoms are not specific. Endometrioid carcinoma and ovarian clear cell carcinoma can originate from endometriosis and are known as endometriosis-related ovarian carcinoma (EAOC). Development of EAOC experimental animal models is needed for basic research and clinical preparation of human tissue tests. This study aimed to determine the role of the Arid1a gene mutation in the carcinogenetic process of EAOC in experimental animal models induced with DMBA. Methods: In this study, the EAOC experimental model was developed using the autoimplantation technique and DMBA induction. This study involved placebo surgery mice (sham), endometrial autoimplantation, and a combination of endometrial autoimplantation and DMBA induction, which were sacrificed at weeks 5, 10, and 20, respectively. Histopathological assessment and immunohistochemical Arid1a staining with an assessment of positive percentages were carried out on 200 cells. Results: This study produced 1 (20%) atypical endometriosis and 1 (20%) clear cell carcinoma at implantation and after 10 weeks of DMBA induction, and 100% endometrioid carcinoma in the DMBA-induced group. Arid1a staining did not show any significant difference (p = 0.313) in all groups. Conclusion: The combination of endometrial autoimplantation techniques and DMBA induction in the ovary produced atypical endometriosis, clear cell carcinoma, and endometrioid carcinoma, where time is an important factor. There was no significant difference in Arid1a expression between the treatment and control groups. © 2021. All Rights Reserved.	Arid1a; DMBA; EAOC; Endometriosis; experimental animal model	ARID1A protein, human; DNA binding protein; transcription factor; animal; autotransplantation; carcinoma; complication; disease model; endometriosis; endometrium; female; metabolism; ovary tumor; pathology; rat; transplantation; Animals; Carcinoma; Disease Models, Animal; DNA-Binding Proteins; Endometriosis; Endometrium; Female; Ovarian Neoplasms; Rats; Transcription Factors; Transplantation, Autologous	Asian Pacific Organization for Cancer Prevention	15137368	33639673	Article	Q2	512	9866	View
875	Lim M.A., Kurniawan A.A.	57216039756;57222011563;	Dreadful Consequences of Sarcopenia and Osteoporosis due to COVID-19 Containment	2021	Geriatric Orthopaedic Surgery and Rehabilitation	12					3	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101012807&doi=10.1177%2f2151459321992746&partnerID=40&md5=a0f3b09ec242d45be8f989650cec89a9	Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Eminence Sports Medicine and Human Performance Center, Jakarta, Indonesia; Department of Sports Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia	Lim, M.A., Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia, Eminence Sports Medicine and Human Performance Center, Jakarta, Indonesia; Kurniawan, A.A., Eminence Sports Medicine and Human Performance Center, Jakarta, Indonesia, Department of Sports Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia	[No abstract available]	Fragility Fractures; Geriatric Trauma; Metabolic Bone disorders; Osteoporosis; Sarcopenia	vitamin D; absorptiometry; anthropometry; bone density; bone fragility; coronavirus disease 2019; dietary intake; dual energy X ray absorptiometry; fracture nonunion; fracture risk assessment; fragility fracture; health care personnel; hip fracture; Letter; lifestyle modification; musculoskeletal injury; osteomyelitis; osteopenia; osteoporosis; physical activity; physical performance; quality of life; sarcopenia; vitamin supplementation	SAGE Publications Inc.	21514585		Letter	-	0	32716	View

Publikasi Scopus 926 artikel (Per 14 Maret 2022)